Latest Perkinelmer (PKI) Headlines PerkinElmer
Post# of 34
Posted On: 03/14/2014 7:18:38 PM
Latest Perkinelmer (PKI) Headlines
PerkinElmer Shares Up 23.4% Since SmarTrend's Buy Recommendation (PKI)
Comtex SmarTrend(R) - Thu Mar 13, 11:10AM CDT
SmarTrend identified an Uptrend for PerkinElmer (NYSE:PKI) on August 2nd, 2013 at $36.63. In approximately 7 months, PerkinElmer has returned 23.41% as of today's recent price of $45.21.
Concise Analysis of the International Electrophoresis Equipment Market - Forecasts to 2016
M2 - Thu Mar 13, 5:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bgc2v8/global) has announced the addition of the "Concise Analysis of the International Electrophoresis Equipment Market - Forecasts to 2016" report to their offering. One of the main trends witnessed in the Global Electrophoresis Equipment market is the increase in mergers and acquisitions. The Global Electrophoresis Equipment market was marked by a number of mergers and acquisitions by leading vendors. These mergers and acquisitions are done with an intention to increase the vendors' global presence, prevent the loss of patents, and achieve economies of scale. For instance, in 2011, Danaher Corp. acquired Beckman Coulter, which has a wide product portfolio of laboratory instruments. In addition, Agilent Technologies Inc. acquired Dako A/S in July 2012 and Accelicon Technologies Inc. in February 2012. According to the report, one of the main factors driving the market is the Increase in Technological Innovations. The latest technological advancements in various healthcare operations and the sophisticated approaches used in them have increased the demand for electrophoresis equipment. New technologies have helped improve the accuracy, cost, sensitivity, and analysis speed of electrophoresis equipment. Further, the report states that one of the main challenges is the intense competition among vendors. The Global Electrophoresis Equipment market is highly fragmented because of the presence of a large number of vendors. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Market Research Methodology 5. Scope of the Report 6. Market Landscape 7. Geographical Segmentation 8. Vendor Landscape 9. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Key Vendor Analysis 16. Other Reports in this Series Companies Mentioned: - Agilent Technologies Inc. - Bio-Rad Laboratories Inc. - C.B.S Scientific Inc. - GE Healthcare Ltd. - Helena Laboratories Corp. - Hoefer Inc. - Life Technologies Corp. - Lonza Group AG - PerkinElmer Inc. - SERVA Electrophoresis GmbH - Sebia S.A. - Thermo Fisher Scientific Inc. For more information visit http://www.researchandmarkets.com/research/bgc2v8/global
Concise Analysis of the International Agricultural and Environmental Diagnostics Market
M2 - Tue Mar 11, 5:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jhcgt6/agricultural_and) has announced the addition of the "Concise Analysis of the International Agricultural and Environmental Diagnostics Market" report to their offering. This report analyzes the worldwide markets for Agricultural and Environmental Diagnostics in US$ Thousand by the following Product Segments: Food Residue Testing, Environmental Residue Testing, and Food Microbiology Testing. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 139 companies including many key and niche players such as: - 3M company - biomerieux SA - Charm Sciences - Idexx Laboratories, Inc. - Life Technologies Corporation - Neogen Corporation - PerkinElmer, Inc. - R-Biopharm AG - Romer Labs? Diagnostic GmbH - Thermo Fisher Scientific, Inc. - VICAM LP - BioControl Systems, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS Study Reliability and Reporting Limitations II. Executive Summary 1. INDUSTRY OVERVIEW 2. FOOD SAFETY TESTING: TRENDS AND ISSUES 3. REGULATORY ENVIRONMENT 4. PRODUCT OVERVIEW 5. GMO TESTING 6. REVIEW OF SELECT TECHNOLOGIES FOR AGRICULTURAL AND ENVIRONMENTAL DIAGNOSTICS 7. PRODUCT INTRODUCTIONS/INNOVATIONS 8. RECENT INDUSTRY ACTIVITY 9. FOCUS ON SELECT PLAYERS 10. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. LATIN AMERICA 7. REST OF WORLD IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 139 (including Divisions/Subsidiaries - 162) - The United States (88) - Canada (5) - Japan (4) - Europe (48) - France (2) - Germany (7) - The United Kingdom (20) - Spain (1) - Rest of Europe (18) - Asia-Pacific (Excluding Japan) (16) - Latin America (1) For more information visit http://www.researchandmarkets.com/research/jhcgt6/agricultural_and
Shares of PKI Up 25.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Mar 06, 9:53AM CST
SmarTrend identified an Uptrend for PerkinElmer (NYSE:PKI) on August 2nd, 2013 at $36.63. In approximately 7 months, PerkinElmer has returned 25.33% as of today's recent price of $45.91.
Audentes Therapeutics Announces Significant Additions to Leadership Team
Business Wire - Tue Mar 04, 7:02AM CST
Audentes Therapeutics, Inc., a biotechnology company dedicated to the development and commercialization of innovative treatments for rare diseases using gene therapy technology, has announced the expansion of its leadership team, including the appointment of Suyash Prasad, M.D. as Senior Vice President and Chief Medical Officer. Dr. Prasad is the latest addition to a management group with significant experience and a history of success in the industry. In addition to Dr. Prasad, Audentes recently appointed Michael O'Callaghan, D.V.M., Ph.D. as Senior Vice President, Preclinical Development and Translational Medicine, Barbara Wuebbels, RN as Vice President, Patient Advocacy and Medical Affairs, and Monica Miller as Vice President, Program and Alliance Management.
Concise Analysis of the Future Prospects of Global Personalized Medicine Market
M2 - Tue Mar 04, 5:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/zpctsr/future_prospects) has announced the addition of the "Concise Analysis of the Future Prospects of Global Personalized Medicine Market" report to their offering. Over the years, the Global Personalized Medicine market has been witnessing the emergence of various tools and technologies from the reputed vendors. For instance, AssureRx Health Inc. launched GeneSightRx ADHD in May 2012, a personalized medicine test for the growing number of children and adults diagnosed with ADHD. Moreover, Bristol-Myers Squibb Co. collaborated with MMRF in December 2012 for advanced personalized medicine for multiple Myeloma. Further, Alacris Theranostics GmbH entered into an agreement with GlaxoSmithKline plc in November 2012 to use ModCell system for early stage cancer research. Further, AltheaDx Inc. launched FLT3 Mutation Assay in October 2012. Agendia N.V. launched ColoPrint microarray-based 18-gene expression signature in June 2012 for predicting the risk of distant recurrence for stage II colon cancer patients. The European Medicines Agency approved Zelboraf, manufactured by F. Hoffmann-La Roche Ltd., in December 2011. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Market Research Methodology 5. Scope of the Report 6. Market Landscape 7. Geographical Segmentation 8. Key Leading Countries 9. Vendor Landscape 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Key Vendor Analysis 17. Other Reports in this Series Companies Mentioned: - Abbott Laboratories - Boehringer Ingelheim GmbH - Bristol-Myers Squibb Co. - Celgene Corp. - Daiichi Sankyo Co. Ltd. - Danaher Corp. - Eli Lilly and Co. - Evotec AG - F. Hoffmann-La Roche Ltd. - GE Healthcare Ltd. - Genelex Corp. - GlaxoSmithKline plc - Hologic Inc. - Johnson & Johnson - Laboratory Corporation of America Holdings - Life Technologies Corp. - Merck KGaA - Mitsubishi Tanabe Pharma Corp. - Myriad Genetics Inc. - Novartis AG - Novartis AG - PerkinElmer Inc. - Pfizer Inc. - Pfizer Inc. - Quest Diagnostics Inc. - Sanofi S.A. - Sanofi S.A. - Siemens Healthcare - Sigma-Aldrich Corp. - Takeda Pharmaceutical Co. Ltd. - Teva Pharmaceutical Industries Ltd. - Thermo Fisher Scientific Inc. - Transgenomic Inc. For more information visit http://www.researchandmarkets.com/research/zpctsr/future_prospects
PerkinElmer Launches Innovative High Throughput Imaging System for Clearer and Faster Visualization of Disease Markers in Tissue
Business Wire - Fri Feb 28, 3:15PM CST
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of the Lamina multilabel slide scanner at the USCAP 2014 Annual Meeting. The Lamina scanner is a high throughput imaging system designed to help research pathologists to more easily study protein expression and the relationships between disease markers in formalin-fixed, paraffin-embedded (FFPE) tissue sections. This allows research pathologists to gain a deeper understanding of diseases for the development of more effective therapies and treatments.
Uptrend Call Working As PerkinElmer Stock Rises 22.3% (PKI)
Comtex SmarTrend(R) - Thu Feb 27, 9:21AM CST
SmarTrend identified an Uptrend for PerkinElmer (NYSE:PKI) on August 2nd, 2013 at $36.63. In approximately 7 months, PerkinElmer has returned 22.28% as of today's recent price of $44.79.
Prenatal Testing Market in the US 2014-2018: Perkinelmer Inc. Expands its Screening Test Offerings, Introducing the First Early Onset Preeclampsia Screening Test in the US in 2013
M2 - Tue Feb 25, 5:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/x2lvh8/prenatal_testing) has announced the addition of the "Prenatal Testing Market in the US 2014-2018" report to their offering. The analysts forecast the Prenatal Testing market in the US to grow at a CAGR of 5.43 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of fetal health-related abnormalities. The Prenatal Testing market in the US has also been witnessing the significant increase in the launch of new tests. However, the falling fertility rates in the US could pose a challenge to the growth of this market. Key vendors dominating this space are PerkinElmer Inc., Quest Diagnostics Inc., Sequenom Inc., and Verinata Health Inc. Other vendors mentioned in the report are ANGLE plc, Ariosa Diagnostics Inc., BGI Health, CellScape Corp., Fluidigm Corp., Ikonisys Inc., Kellbenx Inc., Natera Inc., Ravgen Inc., and Trovagene Inc. Commenting on the report, an analyst from the team said: The Prenatal Testing market in the US is experiencing a significant increase in the number of new tests being launched in the market. For instance, Sequenom launched Laboratoire Cerba's non-invasive prenatal test in San Diego, California, and Saint-Ouen-L'Aumone, France, in December 2013 and enhanced the sequencing series for its MaterniT21 PLUS laboratory-developed test in October 2013. Moreover, PerkinElmer Inc. expanded its prenatal screening test offerings, introducing the first early onset preeclampsia screening test in the US in August 2013. This trend will have a positive impact on the growth of the market. According to the report, one of the major factors driving the market is the increase in the incidence of fetal abnormalities such as Down syndrome, Edwards syndrome, neural tube defects, and genetic defects and disorders such as sickle cell anemia, thalassemia, spina bifida, Tay Sachs disease, cystic fibrosis, muscular dystrophy, cleft palate and fragile X syndrome. For more information visit http://www.researchandmarkets.com/research/x2lvh8/prenatal_testing About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Digital Marketing to Life Scientists: Social Media and Email Best Practices
M2 - Mon Feb 24, 3:20AM CST
Research and Markets (http://www.researchandmarkets.com/research/6sfwnv/digital_marketing) has announced the addition of the "Digital Marketing to Life Scientists: Social Media and Email Best Practices" report to their offering. Digital Marketing to Life Scientists: Social Media and Email Best Practices will help you quantify scientists' preferences and behaviors when it comes to multiple social media platforms and direct outreach via email. This study will provide insight as to the interplay of various digital channels and how they influence customer perceptions and behavior. For suppliers who want to develop a thoughtful social media and email marketing strategy, Digital Marketing to Life Scientists: Social Media and Email Best Practices provides a tactical guide for harnessing the power of the Internet to reach out to customers in a meaningful way. The report identifies where (and how) scientists spend their time on social media platforms and how they rely on email outreach to inform the buying decision. Rather than trial and error (and hoping for the best), vendors can use this primary research to structure their online outreach in a way that inspires scientists to subscribe, read and click through. What does make a scientist click through, and what makes him or her hit delete? When are your customers most receptive to receiving emails from you? How does a supplier become a trusted voice in the social media conversation? Do banner ads work on social sites? Do scientists find science-specific social sites to be more credible/useful? This report explores these questions and more. Additionally, scientists weigh-in on which vendors have gotten the dialog just right - and which ones haven't. Done right, digital marketing is an exciting and cost-effective way to positively impact revenues. Conversely, a heavy price can be paid for missing the mark. Blacklisted by research institutions or companies, added to do-not-send lists, reported as spam, blocked from forums, and losing sales due to an unclear call-to-action, a failed campaign can undermine the entire marketing effort. This study will help suppliers understand the nature of their online relationships with researchers - what engenders customers to a brand and what gets ignored, complained about or dragged into junk. For suppliers who want to master the online conversation, Digital Marketing to Life Scientists: Social Media and Email Best Practices provides data-driven best practices to help optimize electronic marketing platforms in such a way that builds relationship, inspires loyalty and calls a scientist to action. Study Objectives - Understand how life scientists use social media to: -- Engage with life science suppliers. -- Connect, communicate, network, and collaborate with other scientists. - Determine what motivates life scientists to use social media in their professional life. - Identify which social networking sites/platforms are used. - Ascertain the importance of various social networking sites/platforms. - Understand the level of customer engagement with vendor social media. - Reveal the impact of vendor social media on how life scientists interact with their suppliers. - Assess customer receptivity to banner ads located on social media sites. - Understand how life scientists perceive vendor-generated emails. - Pinpoint best email practices to assure customer receptivity. - Detail the expectations of life scientists regarding the privacy of their personal information. - Describe how scientists recommend products and services to their peers. Key Topics Covered: Section 1: Analysis and Interpretation of Survey Results Section 2: Methodology and Demographics Section 3: Appendices Companies Mentioned - AB SCIEX - Abcam - Affymetrix - Agilent Technologies - ATCC - BD Biosciences - Beckman Coulter - Bio-Rad Laboratories - Bruker - Cell Signaling Technologies - Charles River Labs - Corning Life Sciences - EMD Millipore - Eppendorf - Fisher Scientific - GE Healthcare Lifesciences - Illumina - Jackson Labs - Leica Microsystems - Life Technologies - Lonza - Luminex - Molecular Devices - New England Biolabs - Pall - PerkinElmer - Promega - Qiagen - R&D Systems - RainDance Technologies - Roche Applied Science - Shimadzu - Sigma-Aldrich - Taconic - Tecan - Thermo Scientific - VWR - Waters - Zeiss For more information visit http://www.researchandmarkets.com/research/6sfwnv/digital_marketing About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Uptrend Call Working As PerkinElmer Stock Rises 17.4% (PKI)
Comtex SmarTrend(R) - Wed Feb 19, 5:04PM CST
SmarTrend identified an Uptrend for PerkinElmer (NYSE:PKI) on August 2nd, 2013 at $36.63. In approximately 7 months, PerkinElmer has returned 17.36% as of today's recent price of $42.99.
PerkinElmer to Present at Cowen and Company 34th Annual Healthcare Conference
Business Wire - Wed Feb 19, 3:05PM CST
PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that the Company will present at the Cowen and Company Annual Healthcare conference on Wednesday, March 5 at 9:20 am ET at the Marriott Copley Place in Boston.
Insider Trading Alert - PKI, VNTV And TIBX Traded By Insiders
at The Street - Tue Feb 18, 10:00AM CST
Stocks with insider trader activity include PKI, VNTV and TIBX
Agilent Technologies (A) in Focus: Stock Drops 8.0% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 18, 7:46AM CST
Agilent Technologies Inc. (A) saw a big move last session, breaking the recent trend of the company, as the stock is now trading below the volatile price range of $60.93 to $56.15 in the past one-month time frame.
High Content Screening Market to Grow at a CAGR of 11.2% to 2018
M2 - Mon Feb 17, 4:23AM CST
The global high content screening market is a technology-driven market and is marked by the 'Threat of Obsolescence,' wherein technologies as well as their adoption by end users changes very rapidly. Pharmaceutical and biotechnology companies as well as academic and government institutes are increasingly focusing on using high content screening as a powerful research tool in drug discovery.
PerkinElmer Up 20.3% Since SmarTrend Uptrend Call (PKI)
Comtex SmarTrend(R) - Wed Feb 12, 11:13AM CST
SmarTrend identified an Uptrend for PerkinElmer (NYSE:PKI) on August 2nd, 2013 at $36.63. In approximately 6 months, PerkinElmer has returned 20.26% as of today's recent price of $44.05.
Insider Trading Alert - BKU, MANH, PKI, EAT And EXPE Traded By Insiders
at The Street - Wed Feb 12, 9:45AM CST
Stocks with insider trader activity include BKU, MANH, PKI, EAT and EXPE
Global Medical Imaging Reagents Market 2012-2016: Read whats Trending
M2 - Tue Feb 11, 10:33AM CST
Research and Markets (http://www.researchandmarkets.com/research/r2bvff/global_medical) has announced the addition of the "Global Medical Imaging Reagents Market 2012-2016" report to their offering. The analysts forecast the Global Medical Imaging Reagents market to grow at a CAGR of 7.95 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Medical Imaging Reagents market has also been witnessing the increasing demand for radiopharmaceuticals. However, the lack of reimbursements for imaging procedures could pose a challenge to the growth of this market. The key vendors dominating this market space are Bracco S.p.A, Covidien plc, GE Healthcare and Lantheus Medical Imaging Inc. Other vendors mentioned in the report are Aspect Imaging, Bayer AG, Guerbet SA, IBA Molecular Imaging and PerkinElmer Inc. Commenting on the report, an analyst from the team said: As a result of the rise in the incidences of cardiovascular, oncological, and neurological disorders among the population, there has been an increase in the volume of PET, SPECT, SPECT-CT, PET-MRI, and SPECT-MRI procedures for imaging and diagnosis over recent years. Imaging without utilization of radiopharmaceuticals has also become indispensable owing to their ability to diagnose various disease processes much earlier than other diagnostic tests. For instance, it is expected that an increasing number of oncology and cardiology procedures will drive the demand for radiopharmaceuticals such as fluorodeoxyglucose used for PET scans. Thus, the increasing demand for radiopharmaceuticals is expected to fuel the growth in this market. According to the report, one of the main drivers in this market is the increasing global aging population and associated increase in incidences of cardiovascular diseases, neurological disorders, gastrointestinal diseases, and oncologic disorders among the aged population. The rise in demand for diagnostic screening of elderly patients has enhanced the need of imaging reagents. For more information visit http://www.researchandmarkets.com/research/r2bvff/global_medical About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
PerkinElmer Up 15.7% Since SmarTrend Uptrend Call (PKI)
Comtex SmarTrend(R) - Wed Feb 05, 9:52AM CST
SmarTrend identified an Uptrend for PerkinElmer (NYSE:PKI) on August 2nd, 2013 at $36.63. In approximately 6 months, PerkinElmer has returned 15.72% as of today's recent price of $42.39.
Concise Analysis of the International Scientific Instrument Market - Forecasts to 2016
M2 - Wed Feb 05, 3:30AM CST
Research and Markets (http://www.researchandmarkets.com/research/5n3ldg/global_scientific) has announced the addition of the "Concise Analysis of the International Scientific Instrument Market - Forecasts to 2016" report to their offering. The Global Scientific Instrument market is growing at a rapid pace. Therefore, several major players in the market are trying to expand their presence in the market. A number of mergers, acquisitions, and strategic alliances are taking place in the market space. Many big players and emerging contenders in the Global Scientific Instrument market are looking for mergers and acquisitions. Moreover, many vendors are creating alliances with smaller and bigger companies to capture more market share. This enhances their distribution channels and improves their market reach. Thus, mergers and acquisitions help companies remain competitive in the market. One of the major drivers is the increasing demand from developing countries. The process industries in developing and emerging economies such as China, India, South Africa, and Brazil are experiencing high growth. This creates huge potential for the growth of the Global Scientific Instrument market during the forecast period. Rapidly growing process industries such as the Mining and Chemical industries are increasingly adopting general purpose analytical instruments for their elemental analysis and separation analysis processes. Key questions answered in this report: - What will the market size be in 2016 and what will the growth rate be? - What are the key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of the key vendors? Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Coverage 4. Market Landscape 5. Geographical Segmentation 6. Vendor Landscape 7. Market Growth Drivers 8. Drivers and their Impact 9. Market Challenges 10. Impact of Drivers and Challenges 11. Market Trends 12. Key Vendor Analysis 13. Other Reports in this Series Companies Mentioned: - Agilent Technologies - B&W Tek - Bruker - Danaher - HORIBA - Hitachi High-Technologies - Illumina - JASCO - PerkinElmer - Shimadzu - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/5n3ldg/global_scientific
PerkinElmer Shares Up 23.4% Since SmarTrend's Buy Recommendation (PKI)
Comtex SmarTrend(R) - Thu Mar 13, 11:10AM CDT
SmarTrend identified an Uptrend for PerkinElmer (NYSE:PKI) on August 2nd, 2013 at $36.63. In approximately 7 months, PerkinElmer has returned 23.41% as of today's recent price of $45.21.
Concise Analysis of the International Electrophoresis Equipment Market - Forecasts to 2016
M2 - Thu Mar 13, 5:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bgc2v8/global) has announced the addition of the "Concise Analysis of the International Electrophoresis Equipment Market - Forecasts to 2016" report to their offering. One of the main trends witnessed in the Global Electrophoresis Equipment market is the increase in mergers and acquisitions. The Global Electrophoresis Equipment market was marked by a number of mergers and acquisitions by leading vendors. These mergers and acquisitions are done with an intention to increase the vendors' global presence, prevent the loss of patents, and achieve economies of scale. For instance, in 2011, Danaher Corp. acquired Beckman Coulter, which has a wide product portfolio of laboratory instruments. In addition, Agilent Technologies Inc. acquired Dako A/S in July 2012 and Accelicon Technologies Inc. in February 2012. According to the report, one of the main factors driving the market is the Increase in Technological Innovations. The latest technological advancements in various healthcare operations and the sophisticated approaches used in them have increased the demand for electrophoresis equipment. New technologies have helped improve the accuracy, cost, sensitivity, and analysis speed of electrophoresis equipment. Further, the report states that one of the main challenges is the intense competition among vendors. The Global Electrophoresis Equipment market is highly fragmented because of the presence of a large number of vendors. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Market Research Methodology 5. Scope of the Report 6. Market Landscape 7. Geographical Segmentation 8. Vendor Landscape 9. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Key Vendor Analysis 16. Other Reports in this Series Companies Mentioned: - Agilent Technologies Inc. - Bio-Rad Laboratories Inc. - C.B.S Scientific Inc. - GE Healthcare Ltd. - Helena Laboratories Corp. - Hoefer Inc. - Life Technologies Corp. - Lonza Group AG - PerkinElmer Inc. - SERVA Electrophoresis GmbH - Sebia S.A. - Thermo Fisher Scientific Inc. For more information visit http://www.researchandmarkets.com/research/bgc2v8/global
Concise Analysis of the International Agricultural and Environmental Diagnostics Market
M2 - Tue Mar 11, 5:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jhcgt6/agricultural_and) has announced the addition of the "Concise Analysis of the International Agricultural and Environmental Diagnostics Market" report to their offering. This report analyzes the worldwide markets for Agricultural and Environmental Diagnostics in US$ Thousand by the following Product Segments: Food Residue Testing, Environmental Residue Testing, and Food Microbiology Testing. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 139 companies including many key and niche players such as: - 3M company - biomerieux SA - Charm Sciences - Idexx Laboratories, Inc. - Life Technologies Corporation - Neogen Corporation - PerkinElmer, Inc. - R-Biopharm AG - Romer Labs? Diagnostic GmbH - Thermo Fisher Scientific, Inc. - VICAM LP - BioControl Systems, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS Study Reliability and Reporting Limitations II. Executive Summary 1. INDUSTRY OVERVIEW 2. FOOD SAFETY TESTING: TRENDS AND ISSUES 3. REGULATORY ENVIRONMENT 4. PRODUCT OVERVIEW 5. GMO TESTING 6. REVIEW OF SELECT TECHNOLOGIES FOR AGRICULTURAL AND ENVIRONMENTAL DIAGNOSTICS 7. PRODUCT INTRODUCTIONS/INNOVATIONS 8. RECENT INDUSTRY ACTIVITY 9. FOCUS ON SELECT PLAYERS 10. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. LATIN AMERICA 7. REST OF WORLD IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 139 (including Divisions/Subsidiaries - 162) - The United States (88) - Canada (5) - Japan (4) - Europe (48) - France (2) - Germany (7) - The United Kingdom (20) - Spain (1) - Rest of Europe (18) - Asia-Pacific (Excluding Japan) (16) - Latin America (1) For more information visit http://www.researchandmarkets.com/research/jhcgt6/agricultural_and
Shares of PKI Up 25.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Mar 06, 9:53AM CST
SmarTrend identified an Uptrend for PerkinElmer (NYSE:PKI) on August 2nd, 2013 at $36.63. In approximately 7 months, PerkinElmer has returned 25.33% as of today's recent price of $45.91.
Audentes Therapeutics Announces Significant Additions to Leadership Team
Business Wire - Tue Mar 04, 7:02AM CST
Audentes Therapeutics, Inc., a biotechnology company dedicated to the development and commercialization of innovative treatments for rare diseases using gene therapy technology, has announced the expansion of its leadership team, including the appointment of Suyash Prasad, M.D. as Senior Vice President and Chief Medical Officer. Dr. Prasad is the latest addition to a management group with significant experience and a history of success in the industry. In addition to Dr. Prasad, Audentes recently appointed Michael O'Callaghan, D.V.M., Ph.D. as Senior Vice President, Preclinical Development and Translational Medicine, Barbara Wuebbels, RN as Vice President, Patient Advocacy and Medical Affairs, and Monica Miller as Vice President, Program and Alliance Management.
Concise Analysis of the Future Prospects of Global Personalized Medicine Market
M2 - Tue Mar 04, 5:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/zpctsr/future_prospects) has announced the addition of the "Concise Analysis of the Future Prospects of Global Personalized Medicine Market" report to their offering. Over the years, the Global Personalized Medicine market has been witnessing the emergence of various tools and technologies from the reputed vendors. For instance, AssureRx Health Inc. launched GeneSightRx ADHD in May 2012, a personalized medicine test for the growing number of children and adults diagnosed with ADHD. Moreover, Bristol-Myers Squibb Co. collaborated with MMRF in December 2012 for advanced personalized medicine for multiple Myeloma. Further, Alacris Theranostics GmbH entered into an agreement with GlaxoSmithKline plc in November 2012 to use ModCell system for early stage cancer research. Further, AltheaDx Inc. launched FLT3 Mutation Assay in October 2012. Agendia N.V. launched ColoPrint microarray-based 18-gene expression signature in June 2012 for predicting the risk of distant recurrence for stage II colon cancer patients. The European Medicines Agency approved Zelboraf, manufactured by F. Hoffmann-La Roche Ltd., in December 2011. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Market Research Methodology 5. Scope of the Report 6. Market Landscape 7. Geographical Segmentation 8. Key Leading Countries 9. Vendor Landscape 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Key Vendor Analysis 17. Other Reports in this Series Companies Mentioned: - Abbott Laboratories - Boehringer Ingelheim GmbH - Bristol-Myers Squibb Co. - Celgene Corp. - Daiichi Sankyo Co. Ltd. - Danaher Corp. - Eli Lilly and Co. - Evotec AG - F. Hoffmann-La Roche Ltd. - GE Healthcare Ltd. - Genelex Corp. - GlaxoSmithKline plc - Hologic Inc. - Johnson & Johnson - Laboratory Corporation of America Holdings - Life Technologies Corp. - Merck KGaA - Mitsubishi Tanabe Pharma Corp. - Myriad Genetics Inc. - Novartis AG - Novartis AG - PerkinElmer Inc. - Pfizer Inc. - Pfizer Inc. - Quest Diagnostics Inc. - Sanofi S.A. - Sanofi S.A. - Siemens Healthcare - Sigma-Aldrich Corp. - Takeda Pharmaceutical Co. Ltd. - Teva Pharmaceutical Industries Ltd. - Thermo Fisher Scientific Inc. - Transgenomic Inc. For more information visit http://www.researchandmarkets.com/research/zpctsr/future_prospects
PerkinElmer Launches Innovative High Throughput Imaging System for Clearer and Faster Visualization of Disease Markers in Tissue
Business Wire - Fri Feb 28, 3:15PM CST
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of the Lamina multilabel slide scanner at the USCAP 2014 Annual Meeting. The Lamina scanner is a high throughput imaging system designed to help research pathologists to more easily study protein expression and the relationships between disease markers in formalin-fixed, paraffin-embedded (FFPE) tissue sections. This allows research pathologists to gain a deeper understanding of diseases for the development of more effective therapies and treatments.
Uptrend Call Working As PerkinElmer Stock Rises 22.3% (PKI)
Comtex SmarTrend(R) - Thu Feb 27, 9:21AM CST
SmarTrend identified an Uptrend for PerkinElmer (NYSE:PKI) on August 2nd, 2013 at $36.63. In approximately 7 months, PerkinElmer has returned 22.28% as of today's recent price of $44.79.
Prenatal Testing Market in the US 2014-2018: Perkinelmer Inc. Expands its Screening Test Offerings, Introducing the First Early Onset Preeclampsia Screening Test in the US in 2013
M2 - Tue Feb 25, 5:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/x2lvh8/prenatal_testing) has announced the addition of the "Prenatal Testing Market in the US 2014-2018" report to their offering. The analysts forecast the Prenatal Testing market in the US to grow at a CAGR of 5.43 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of fetal health-related abnormalities. The Prenatal Testing market in the US has also been witnessing the significant increase in the launch of new tests. However, the falling fertility rates in the US could pose a challenge to the growth of this market. Key vendors dominating this space are PerkinElmer Inc., Quest Diagnostics Inc., Sequenom Inc., and Verinata Health Inc. Other vendors mentioned in the report are ANGLE plc, Ariosa Diagnostics Inc., BGI Health, CellScape Corp., Fluidigm Corp., Ikonisys Inc., Kellbenx Inc., Natera Inc., Ravgen Inc., and Trovagene Inc. Commenting on the report, an analyst from the team said: The Prenatal Testing market in the US is experiencing a significant increase in the number of new tests being launched in the market. For instance, Sequenom launched Laboratoire Cerba's non-invasive prenatal test in San Diego, California, and Saint-Ouen-L'Aumone, France, in December 2013 and enhanced the sequencing series for its MaterniT21 PLUS laboratory-developed test in October 2013. Moreover, PerkinElmer Inc. expanded its prenatal screening test offerings, introducing the first early onset preeclampsia screening test in the US in August 2013. This trend will have a positive impact on the growth of the market. According to the report, one of the major factors driving the market is the increase in the incidence of fetal abnormalities such as Down syndrome, Edwards syndrome, neural tube defects, and genetic defects and disorders such as sickle cell anemia, thalassemia, spina bifida, Tay Sachs disease, cystic fibrosis, muscular dystrophy, cleft palate and fragile X syndrome. For more information visit http://www.researchandmarkets.com/research/x2lvh8/prenatal_testing About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Digital Marketing to Life Scientists: Social Media and Email Best Practices
M2 - Mon Feb 24, 3:20AM CST
Research and Markets (http://www.researchandmarkets.com/research/6sfwnv/digital_marketing) has announced the addition of the "Digital Marketing to Life Scientists: Social Media and Email Best Practices" report to their offering. Digital Marketing to Life Scientists: Social Media and Email Best Practices will help you quantify scientists' preferences and behaviors when it comes to multiple social media platforms and direct outreach via email. This study will provide insight as to the interplay of various digital channels and how they influence customer perceptions and behavior. For suppliers who want to develop a thoughtful social media and email marketing strategy, Digital Marketing to Life Scientists: Social Media and Email Best Practices provides a tactical guide for harnessing the power of the Internet to reach out to customers in a meaningful way. The report identifies where (and how) scientists spend their time on social media platforms and how they rely on email outreach to inform the buying decision. Rather than trial and error (and hoping for the best), vendors can use this primary research to structure their online outreach in a way that inspires scientists to subscribe, read and click through. What does make a scientist click through, and what makes him or her hit delete? When are your customers most receptive to receiving emails from you? How does a supplier become a trusted voice in the social media conversation? Do banner ads work on social sites? Do scientists find science-specific social sites to be more credible/useful? This report explores these questions and more. Additionally, scientists weigh-in on which vendors have gotten the dialog just right - and which ones haven't. Done right, digital marketing is an exciting and cost-effective way to positively impact revenues. Conversely, a heavy price can be paid for missing the mark. Blacklisted by research institutions or companies, added to do-not-send lists, reported as spam, blocked from forums, and losing sales due to an unclear call-to-action, a failed campaign can undermine the entire marketing effort. This study will help suppliers understand the nature of their online relationships with researchers - what engenders customers to a brand and what gets ignored, complained about or dragged into junk. For suppliers who want to master the online conversation, Digital Marketing to Life Scientists: Social Media and Email Best Practices provides data-driven best practices to help optimize electronic marketing platforms in such a way that builds relationship, inspires loyalty and calls a scientist to action. Study Objectives - Understand how life scientists use social media to: -- Engage with life science suppliers. -- Connect, communicate, network, and collaborate with other scientists. - Determine what motivates life scientists to use social media in their professional life. - Identify which social networking sites/platforms are used. - Ascertain the importance of various social networking sites/platforms. - Understand the level of customer engagement with vendor social media. - Reveal the impact of vendor social media on how life scientists interact with their suppliers. - Assess customer receptivity to banner ads located on social media sites. - Understand how life scientists perceive vendor-generated emails. - Pinpoint best email practices to assure customer receptivity. - Detail the expectations of life scientists regarding the privacy of their personal information. - Describe how scientists recommend products and services to their peers. Key Topics Covered: Section 1: Analysis and Interpretation of Survey Results Section 2: Methodology and Demographics Section 3: Appendices Companies Mentioned - AB SCIEX - Abcam - Affymetrix - Agilent Technologies - ATCC - BD Biosciences - Beckman Coulter - Bio-Rad Laboratories - Bruker - Cell Signaling Technologies - Charles River Labs - Corning Life Sciences - EMD Millipore - Eppendorf - Fisher Scientific - GE Healthcare Lifesciences - Illumina - Jackson Labs - Leica Microsystems - Life Technologies - Lonza - Luminex - Molecular Devices - New England Biolabs - Pall - PerkinElmer - Promega - Qiagen - R&D Systems - RainDance Technologies - Roche Applied Science - Shimadzu - Sigma-Aldrich - Taconic - Tecan - Thermo Scientific - VWR - Waters - Zeiss For more information visit http://www.researchandmarkets.com/research/6sfwnv/digital_marketing About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Uptrend Call Working As PerkinElmer Stock Rises 17.4% (PKI)
Comtex SmarTrend(R) - Wed Feb 19, 5:04PM CST
SmarTrend identified an Uptrend for PerkinElmer (NYSE:PKI) on August 2nd, 2013 at $36.63. In approximately 7 months, PerkinElmer has returned 17.36% as of today's recent price of $42.99.
PerkinElmer to Present at Cowen and Company 34th Annual Healthcare Conference
Business Wire - Wed Feb 19, 3:05PM CST
PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that the Company will present at the Cowen and Company Annual Healthcare conference on Wednesday, March 5 at 9:20 am ET at the Marriott Copley Place in Boston.
Insider Trading Alert - PKI, VNTV And TIBX Traded By Insiders
at The Street - Tue Feb 18, 10:00AM CST
Stocks with insider trader activity include PKI, VNTV and TIBX
Agilent Technologies (A) in Focus: Stock Drops 8.0% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 18, 7:46AM CST
Agilent Technologies Inc. (A) saw a big move last session, breaking the recent trend of the company, as the stock is now trading below the volatile price range of $60.93 to $56.15 in the past one-month time frame.
High Content Screening Market to Grow at a CAGR of 11.2% to 2018
M2 - Mon Feb 17, 4:23AM CST
The global high content screening market is a technology-driven market and is marked by the 'Threat of Obsolescence,' wherein technologies as well as their adoption by end users changes very rapidly. Pharmaceutical and biotechnology companies as well as academic and government institutes are increasingly focusing on using high content screening as a powerful research tool in drug discovery.
PerkinElmer Up 20.3% Since SmarTrend Uptrend Call (PKI)
Comtex SmarTrend(R) - Wed Feb 12, 11:13AM CST
SmarTrend identified an Uptrend for PerkinElmer (NYSE:PKI) on August 2nd, 2013 at $36.63. In approximately 6 months, PerkinElmer has returned 20.26% as of today's recent price of $44.05.
Insider Trading Alert - BKU, MANH, PKI, EAT And EXPE Traded By Insiders
at The Street - Wed Feb 12, 9:45AM CST
Stocks with insider trader activity include BKU, MANH, PKI, EAT and EXPE
Global Medical Imaging Reagents Market 2012-2016: Read whats Trending
M2 - Tue Feb 11, 10:33AM CST
Research and Markets (http://www.researchandmarkets.com/research/r2bvff/global_medical) has announced the addition of the "Global Medical Imaging Reagents Market 2012-2016" report to their offering. The analysts forecast the Global Medical Imaging Reagents market to grow at a CAGR of 7.95 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Medical Imaging Reagents market has also been witnessing the increasing demand for radiopharmaceuticals. However, the lack of reimbursements for imaging procedures could pose a challenge to the growth of this market. The key vendors dominating this market space are Bracco S.p.A, Covidien plc, GE Healthcare and Lantheus Medical Imaging Inc. Other vendors mentioned in the report are Aspect Imaging, Bayer AG, Guerbet SA, IBA Molecular Imaging and PerkinElmer Inc. Commenting on the report, an analyst from the team said: As a result of the rise in the incidences of cardiovascular, oncological, and neurological disorders among the population, there has been an increase in the volume of PET, SPECT, SPECT-CT, PET-MRI, and SPECT-MRI procedures for imaging and diagnosis over recent years. Imaging without utilization of radiopharmaceuticals has also become indispensable owing to their ability to diagnose various disease processes much earlier than other diagnostic tests. For instance, it is expected that an increasing number of oncology and cardiology procedures will drive the demand for radiopharmaceuticals such as fluorodeoxyglucose used for PET scans. Thus, the increasing demand for radiopharmaceuticals is expected to fuel the growth in this market. According to the report, one of the main drivers in this market is the increasing global aging population and associated increase in incidences of cardiovascular diseases, neurological disorders, gastrointestinal diseases, and oncologic disorders among the aged population. The rise in demand for diagnostic screening of elderly patients has enhanced the need of imaging reagents. For more information visit http://www.researchandmarkets.com/research/r2bvff/global_medical About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
PerkinElmer Up 15.7% Since SmarTrend Uptrend Call (PKI)
Comtex SmarTrend(R) - Wed Feb 05, 9:52AM CST
SmarTrend identified an Uptrend for PerkinElmer (NYSE:PKI) on August 2nd, 2013 at $36.63. In approximately 6 months, PerkinElmer has returned 15.72% as of today's recent price of $42.39.
Concise Analysis of the International Scientific Instrument Market - Forecasts to 2016
M2 - Wed Feb 05, 3:30AM CST
Research and Markets (http://www.researchandmarkets.com/research/5n3ldg/global_scientific) has announced the addition of the "Concise Analysis of the International Scientific Instrument Market - Forecasts to 2016" report to their offering. The Global Scientific Instrument market is growing at a rapid pace. Therefore, several major players in the market are trying to expand their presence in the market. A number of mergers, acquisitions, and strategic alliances are taking place in the market space. Many big players and emerging contenders in the Global Scientific Instrument market are looking for mergers and acquisitions. Moreover, many vendors are creating alliances with smaller and bigger companies to capture more market share. This enhances their distribution channels and improves their market reach. Thus, mergers and acquisitions help companies remain competitive in the market. One of the major drivers is the increasing demand from developing countries. The process industries in developing and emerging economies such as China, India, South Africa, and Brazil are experiencing high growth. This creates huge potential for the growth of the Global Scientific Instrument market during the forecast period. Rapidly growing process industries such as the Mining and Chemical industries are increasingly adopting general purpose analytical instruments for their elemental analysis and separation analysis processes. Key questions answered in this report: - What will the market size be in 2016 and what will the growth rate be? - What are the key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of the key vendors? Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Coverage 4. Market Landscape 5. Geographical Segmentation 6. Vendor Landscape 7. Market Growth Drivers 8. Drivers and their Impact 9. Market Challenges 10. Impact of Drivers and Challenges 11. Market Trends 12. Key Vendor Analysis 13. Other Reports in this Series Companies Mentioned: - Agilent Technologies - B&W Tek - Bruker - Danaher - HORIBA - Hitachi High-Technologies - Illumina - JASCO - PerkinElmer - Shimadzu - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/5n3ldg/global_scientific
(0)
(0)Perkinelmer (PKI) Stock Research Links
Scroll down for more posts ▼